Status:
UNKNOWN
Role of Blood Lactate Level in Prediction of Outcome of Cirrhotic Patients at The Intensive Care Unit
Lead Sponsor:
Assiut University
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18+ years
Brief Summary
1. Determine in-hospital and 28-days mortality rates of critically-ill cirrhotic patients admitted to ICU 2. Evaluate the role of (blood lactate level, lactate/albumin ratio, lactate/bilirubin index a...
Detailed Description
Liver cirrhosis is a major health problem, which causes high mortality and economic burden worldwide. A large number of liver cirrhosis patients are prone to acute decompensation with organ failure, t...
Eligibility Criteria
Inclusion
- Cirrhotic patients who are at least 18 years old at their first ICU admission in Al-Rajhy University Hospital (according to the established admission policy) and stay more than 24 h will be included.
Exclusion
- 1\) Patients admitted for liver transplantation.
- 2\) Patients whose blood lactate data is lost at 24 hours from ICU admission.
- 3\) Patients taking drugs that increase level of serum lactate as metformin , acetaminophen, linezolid, epinephrine, beta2 agonists, propofol, nucleoside reverse transcriptase inhibitors (NRTIs) as lamivudine and abacavir , and theophylline
Key Trial Info
Start Date :
November 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06121908
Start Date
November 15 2023
End Date
November 1 2024
Last Update
November 8 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.